Skip to content
AwardedSpainGoods€237,156

Lote 1, ALMERÍA 2º CBAM CONTR 2025 0000507008_2

Published
Published 17 June 2026

Overview

Merck Sharp & Dohme de España, S.A. was awarded a framework call-off contract on 15 June 2026 for the supply of nonavalent human papillomavirus vaccines (HPV-9) to the Andalusian Vaccination Programme, with a contract value of €246,642.62. The procurement is now complete.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€237,156
Procedure
Direct
Published
17 June 2026
Classification (CPV)
Vaccines

Award outcome

Awarded value
€246,643
Award date
15 June 2026
Winner
  • MERCK SHARP & DOHME DE ESPAÑA, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    17 June 2026

Contracting authority

  • Servicio Andaluz de Salud. Central Provincial de Compras de Almería

    Procuring entity

    Almería, Spain

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Lote 1, ALMERÍA 2º CBAM CONTR 2025 0000507008_2 — won by MERCK SHARP & DOHME DE ESPAÑA, S.A. — Skim